(Q46516165)
Statements
1 reference
Remogliflozin etabonate, in a novel category of selective low-affinity sodium glucose cotransporter (SGLT2) inhibitors, exhibits antidiabetic efficacy in rodent models (English)
1 reference
Yoshikazu Fujimori
1 reference
Kenji Katsuno
1 reference
Ikumi Nakashima
1 reference
Yukiko Ishikawa-Takemura
1 reference
Hideki Fujikura
1 reference
Masayuki Isaji
1 reference
26 June 2008
1 reference
327
1 reference
1
1 reference
268-276
1 reference
Identifiers
1 reference